Concepedia

M Aristides

MA

Statistics

Publications

8

Citations

355

H-Index

8

Active since

1994

Affiliations

Eli Lilly (United States)(Current)

The University of Sydney

Eli Lilly (United Kingdom)

M Aristides is an author at Eli Lilly (United States) specializing in pharmacoeconomics, pharmacoeconomic evaluation, and pharmacy.

Publications per year

1994–2004

8

Publications

8

Economic evaluation of standard heparin and enoxaparin for prophylaxis against deep vein thrombosis in elective hip surgery

M Drummond, M Aristides, Linda Davies et al. · British journal of surgery · 1994 · 73 citations

Medicine, Orthopaedic Surgery, Surgery +17

Patient Preference and Willingness-to-Pay for Humalog Mix25 Relative to Humulin 30/70: A Multicountry Application of a Discrete Choice Experiment

M Aristides, Adèle Weston, Patrick Fitzgerald et al. · Value in Health · 2004 · 65 citations · Full text

Natural Resources, Behavioral Sciences, Economics +17

Economic Impact of Increased Clinical Intervention Rates in Community Pharmacy

Shalom I. Benrimoj, Jane Langford, Geoffrey Berry et al. · PharmacoEconomics · 2000 · 60 citations

Pharmacy, Community Pharmacy, Pharmacoeconomics +15

Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe

Joan H. Schiller, Dominic Tilden, M Aristides et al. · Lung Cancer · 2003 · 45 citations

Medicine, Oncology, Pharmacoeconomics +15

Economic Evaluation of Gemcitabine Alone and in Combination with Cisplatin in the Treatment of Nonsmall Cell Lung Cancer

M Lees, M Aristides, N Maniadakis et al. · PharmacoEconomics · 2002 · 45 citations

Medicine, Oncology, Pharmacoeconomics +16

1–5 of 8